Clinical trials
Observational Diabetes Mellitus, Type 2 trials in Saudi Arabia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2022 | 3 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 13 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Boehringer Ingelheim | 1 |
| Eli Lilly and Company | 1 |
| King Saud University | 1 |
| Ministry of Health, Saudi Arabia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 19 |
| Diabetes Mellitus | 7 |
| Diabetes Mellitus, Type 1 | 3 |
| Disease Progression | 1 |
| Hypoglycemia | 1 |
| Insulin Resistance | 1 |
| Neoplasms | 1 |
| Non-alcoholic Fatty Liver Disease | 1 |
| Renal Insufficiency, Chronic | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.